TipRanks
Go Ultimate55% OFF

Luke Miels Insider Profile

4 Followers

Luke Miels, Chief Executive Officer at GlaxoSmithKline, holds ― shares in GlaxoSmithKline (Ticker: GB:GSK), holds ― shares in AstraZeneca (Ticker: GB:AZN).

Luke Miels's Trading History

GSK
GlaxoSmithKline
Oct 14, 2026Chief Executive OfficerUninformative Buy24.52K―
AZN
AstraZeneca
May 23, 2016Executive Vice-PresidentUninformative Buy――

You May Also Like

Luke Miels insider profile FAQ

What is the percentage of profitable transactions made by Luke Miels?
The percentage of profitable transactions made by Luke Miels is 50%.
What is the average return per transaction made by Luke Miels?
The average return per transaction made by Luke Miels is -7.80%.
What stocks does Luke Miels hold?
Luke Miels holds: GB:GSK, GB:AZN stocks.
What was Luke Miels’s latest transaction?
Luke Miels’s latest transaction was an Uninformative Buy of 24.52K .
What was Luke Miels's most profitable transaction?
Luke Miels’s most profitable transaction was an Informative Sell of GB:GSK stock on February 20, 2020. The return on the trade was 22.20%.
What is Luke Miels's role in GlaxoSmithKline?
Luke Miels's role in GlaxoSmithKline is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.